NCT01377844View on ClinicalTrials.gov

Efficacy and Safety of EGT0001442 in Patients With Type 2 Diabetes Mellitus

PHASE2CompletedINTERVENTIONAL

Enrollment

288

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

November 30, 2013

Study Completion Date

December 31, 2013

Conditions

Diabetes Mellitus

Interventions

DRUG

EGT0001442

DRUG

Placebo

Trial Locations (11)

Unknown

Site 5, Buena Park

Site 4, Los Angeles

Site 3, Santa Ana

Site 1, Hialeah

Site 9, Berlin

Site 7, Cary

Site 6, Marion

Site 8, Munroe Falls

Site 2, Portland

Site 11, North Richland Hills

Site 7, San Antonio

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Theracos

INDUSTRY

NCT01377844 - Efficacy and Safety of EGT0001442 in Patients With Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter